Literature DB >> 20883235

Managing hypertensive patients with gout who take thiazide.

Joel Handler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20883235      PMCID： PMC8672996          DOI： 10.1111/j.1751-7176.2010.00346.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  29 in total

Review 1.  The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?

Authors:  Asterios Karagiannis; Dimitri P Mikhailidis; Vasilios G Athyros; Anna I Kakafika; Konstantinos Tziomalos; Evangelos N Liberopoulos; Matilda Florentin; Moses Elisaf
Journal:  Expert Opin Ther Targets       Date:  2007-02       Impact factor: 6.902

2.  Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.

Authors:  Bryan Williams; Peter S Lacy; Simon M Thom; Kennedy Cruickshank; Alice Stanton; David Collier; Alun D Hughes; H Thurston; Michael O'Rourke
Journal:  Circulation       Date:  2006-02-13       Impact factor: 29.690

Review 3.  Epidemiology of gout.

Authors:  Arthur L Weaver
Journal:  Cleve Clin J Med       Date:  2008-07       Impact factor: 2.321

4.  Resistant hypertension revisited: a comparison of two university-based cohorts.

Authors:  Jay P Garg; William J Elliott; Amy Folker; Munavvar Izhar; Henry R Black
Journal:  Am J Hypertens       Date:  2005-05       Impact factor: 2.689

5.  Predicting acute gout in diuretic-treated hypertensive patients.

Authors:  P C Waller; L E Ramsay
Journal:  J Hum Hypertens       Date:  1989-12       Impact factor: 3.012

6.  Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients.

Authors:  Toshihiro Hamada; Kimiyoshi Ichida; Makoto Hosoyamada; Einosuke Mizuta; Kiyotaka Yanagihara; Kazuhiko Sonoyama; Shinobu Sugihara; Osamu Igawa; Tatsuo Hosoya; Akira Ohtahara; Chiaki Shigamasa; Yasutaka Yamamoto; Haruaki Ninomiya; Ichiro Hisatome
Journal:  Am J Hypertens       Date:  2008-07-31       Impact factor: 2.689

7.  Hydrochlorothiazide and spironolactone in hypertension.

Authors:  G Schrijver; M H Weinberger
Journal:  Clin Pharmacol Ther       Date:  1979-01       Impact factor: 6.875

Review 8.  Uric acid and cardiovascular risk.

Authors:  Daniel I Feig; Duk-Hee Kang; Richard J Johnson
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

9.  Effects of losartan on a background of hydrochlorothiazide in patients with hypertension.

Authors:  B A Soffer; J T Wright; J H Pratt; B Wiens; A I Goldberg; C S Sweet
Journal:  Hypertension       Date:  1995-07       Impact factor: 10.190

10.  Hyperuricemia in childhood primary hypertension.

Authors:  Daniel I Feig; Richard J Johnson
Journal:  Hypertension       Date:  2003-08-04       Impact factor: 10.190
View more
  1 in total

Review 1.  Lesinurad: A significant advancement or just another addition to existing therapies of gout?

Authors:  Ajay Gupta; Pramod Kumar Sharma; Arup Kumar Misra; Surjit Singh
Journal:  J Pharmacol Pharmacother       Date:  2016 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.